Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 3/04: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents
A61P 3/04
Sub-Class
Stats
- 836 US PATENTS IN FORCE
- 393 US APPLICATIONS PENDING
- 200 Total Patent Owners
- 11,298 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12263159 | Fused ring compound having urea structure | Jan 23, 24 | Apr 01, 25 | Sanford Burnham Prebys Medical Discovery Institute |
| 12263202 | Method of treating melanocortin-4 receptor pathway-associated disorders | Feb 09, 21 | Apr 01, 25 | RHYTHM PHARMACEUTICALS, INC. |
| 12263206 | Pharmaceutical composition for preventing or treating obesity or sarcopenia, containing IF1 as active ingredient | Sep 11, 19 | Apr 01, 25 | Medi&Gene Inc. |
| 12257217 | Compositions and methods for treating hyperphagia in prader-willi syndrome | Oct 15, 22 | Mar 25, 25 | Purdue Research Foundation |
| 12257271 | sp. bacterium and use thereof | Dec 24, 19 | Mar 25, 25 | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) |
| 12257287 | Glucagon-derived peptide and use thereof | Nov 12, 19 | Mar 25, 25 | TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. |
| 12258367 | Glucoside derivative that acts as SGLT1 inhibitor and application thereof | Mar 30, 20 | Mar 25, 25 | MEDSHINE DISCOVERY INC. |
| 12258609 | Method for producing glycerides of hydroxycarboxylic acids | Jan 23, 19 | Mar 25, 25 | KETOLIPIX THERAPEUTICS GMBH |
| 12251362 | Administration of R-beta-hydroxybutyrate and related compounds in humans | Jul 07, 23 | Mar 18, 25 | AXCESS GLOBAL SCIENCES, LLC |
| 12252524 | GIP/GLP1 co-agonist compounds | Jul 02, 21 | Mar 18, 25 | Eli Lilly and Company |
| 12246002 | Pharmaceutical composition for prevention or treatment of circadian rhythm-related disorders, comprising oxyiminomethylbenzene derivative as active ingredient | Sep 27, 19 | Mar 11, 25 | Korea University Research and Business Foundation; KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION; |
| 12239630 | Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor | Apr 07, 23 | Mar 04, 25 | Bayer Pharma Aktiengesellschaft |
| 12239674 | LRH05 isolate, and composition including the same and use thereof | Jun 17, 21 | Mar 04, 25 | SYNBIO TECH INC. |
| 12239739 | Oral dosing of GLP-1 compounds | Mar 22, 19 | Mar 04, 25 | Novo Nordisk A/S |
| 12226442 | oil and surface-active agents | Nov 07, 19 | Feb 18, 25 | N.S. OILS LTD. |
| 12226487 | Therapeutic derivatives of interleukin-22 | Apr 05, 24 | Feb 18, 25 | Cytoki Pharma ApS |
| 12227509 | Dihydropyrazolopyrazinone derivative having MGAT2 inhibitory activity | Jan 10, 20 | Feb 18, 25 | SHIONOGI & CO. LTD. A LEGAL ENTITY OF JAPAN |
| 12220391 | Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy | Aug 08, 22 | Feb 11, 25 | Metaolic Technologies, LLC |
| 12220406 | Compositions for the prevention and treatment of metabolic syndrome | Jun 10, 21 | Feb 11, 25 | Not available |
| 12213990 | A3 adenosine receptor ligand for use for achieving a fat loss effect | Jan 05, 20 | Feb 04, 25 | Can-Fite Biopharma Ltd. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0114,387 | PHARMACEUTICAL COMPOSITION COMPRISING ENAVOGLIFLOZIN FOR PREVENTING OR TREATING OBESITY IN CANINE ANIMALS | Jan 20, 23 | Apr 10, 25 | Not available |
| 2025/0114,419 | INTESTINAL HEALTH PROMOTING COMPOSITIONS | Aug 12, 24 | Apr 10, 25 | Not available |
| 2025/0114,422 | COMPOSITION FOR LIPOLYSIS COMPRISING EXTRACT OF MORUS ALBA L. BARK AND MAGNOLIA OFFICINALIS BARK AS ACTIVE INGREDIENT | Feb 09, 23 | Apr 10, 25 | BOINBIO-CONVERGENCE CO., LTD. |
| 2025/0114,426 | USE OF COLLAGEN HYDROLYSATE IN PREVENTION AND/OR TREATMENT OF FOOD CRAVING | Feb 01, 23 | Apr 10, 25 | Not available |
| 2025/0115,654 | PHARMACEUTICAL COMPOSITION OF GLP-1 RECEPTOR AND GIP RECEPTOR DUAL AGONIST, AND USE THEREOF | Nov 11, 22 | Apr 10, 25 | Not available |
| 2025/0115,672 | CANINE ANTI-NGF ANTIBODIES AND METHODS OF TREATING PAIN THEREOF | Jun 13, 24 | Apr 10, 25 | Not available |
| 2025/0108,020 | COMPOSITIONS AND COMPOUNDS CONTAINNG BETA-HYDROXYBUTYRATE AND ONE OR MORE AMINO ACIDS | Dec 11, 24 | Apr 03, 25 | Not available |
| 2025/0108,038 | SUBSTITUTED DERIVATIVES OF ISOINDOLES AND USES THEREOF | Sep 27, 24 | Apr 03, 25 | Supernus Pharmaceuticals, Inc. |
| 2025/0109,168 | POLYPEPTIDE AND USE THEREOF IN REGULATING BLOOD GLUCOSE LEVEL AND/OR REDUCING FAT | Sep 24, 24 | Apr 03, 25 | Not available |
| 2025/0109,191 | METHODS FOR ALTERING BODY COMPOSITION BY ADMINISTERING A GDF8 INHIBITOR AND AN ACTIVIN A INHIBITOR | Oct 09, 24 | Apr 03, 25 | Not available |
| 2025/0099,411 | Methods of Treatment of Inflammation Related Conditions Using Pluripotent Anti-Inflammatory and Metabolic Modulators | Apr 24, 24 | Mar 27, 25 | Institut Pasteur de Montevideo; Universidad de la República; |
| 2025/0099,452 | COMPOSITIONS COMPRISING MIXTURES OF COMPOUNDS AND USES THEREOF | Dec 10, 24 | Mar 27, 25 | Not available |
| 2025/0090,485 | COMPOSITIONS CONTAINING HMB AND KETONE BODIES AND METHODS FOR INCREASING LEAN-TO-FAT MASS RATIO | Nov 25, 24 | Mar 20, 25 | Not available |
| 2025/0092,041 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | Nov 22, 24 | Mar 20, 25 | Chugai Seiyaku Kabushiki Kaisha |
| 2025/0082,717 | COMPOSITIONS FOR TREATING KIDNEY DISEASE | May 03, 24 | Mar 13, 25 | Not available |
| 2025/0084,142 | LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE | Sep 18, 24 | Mar 13, 25 | Not available |
| 2025/0084,144 | DUAL-TARGET FUSION PROTEINS COMPRISING FGF21 AND GLP-1, CONNECTED THROUGH A FC PORTION OF AN IMMUNOGLOBULIN | Aug 15, 24 | Mar 13, 25 | SUNSHINE LAKE PHARMA CO., LTD |
| 2025/0084,388 | ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF | Jun 20, 24 | Mar 13, 25 | Not available |
| 2025/0074,964 | STABLE GLP-1 ANALOGS FOR THE TREATMENT OF HUMAN DISEASE AND DISORDERS | Sep 05, 24 | Mar 06, 25 | Not available |
| 2025/0075,168 | METHOD FOR REGULATING BLOOD GLUCOSE, LOSING WEIGHT, AND REDUCING PRODUCTION OF ADVANCED GLYCATION END PRODUCTS BY USING SACCHAROMYCES CEREVISIAE TCI907 AND/OR METABOLITE THEREOF | Jan 25, 24 | Mar 06, 25 | Not available |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)